Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 3;15(1):103.
doi: 10.1186/s13195-023-01251-4.

APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia

Affiliations

APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia

Ashwati Vipin et al. Alzheimers Res Ther. .

Abstract

Background: White matter hyperintensities, a neuroimaging marker of small-vessel cerebrovascular disease and apolipoprotein ε4 (APOE4) allele, are important dementia risk factors. However, APOE4 as a key effect modifier in the relationship between white matter hyperintensities and grey matter volume needs further exploration.

Methods: One hundred ninety-two early-stage dementia (including mild cognitive impairment and mild dementia) and 259 cognitively unimpaired participants from a neurocognitive research cohort with neuroimaging data, APOE genotyping, and neuropsychological assessments were studied. We investigated independent and interactive effects of white matter hyperintensities and APOE4 on whole-brain voxel-wise grey matter volume using voxel-based morphometry (uncorrected p < 0.001; minimum cluster size = 100 voxels). We further assessed interactive effects between APOE4 and white matter hyperintensities on global cognition, memory, and executive function in early-stage dementia and cognitively unimpaired participants.

Results: Independent of APOE4 status, higher white matter hyperintensity load was associated with greater grey matter atrophy across frontal, parietal, temporal, and occipital lobes in cognitively unimpaired and early-stage dementia subjects. However, interaction analyses and independent sample analyses revealed that APOE4 non-carriers demonstrated greater white matter hyperintensity-associated grey matter atrophy compared to APOE4 carriers in both cognitively unimpaired and early-stage dementia groups. Additional confirmatory analyses among APOE4 non-carriers demonstrated that white matter hyperintensities resulted in widespread grey matter loss. Analyses of cognitive function demonstrated that higher white matter hyperintensity load was associated with worse global (Mini-Mental State Examination, Montreal Cognitive Assessment) and executive function (Color Trails 2) in APOE4 non-carriers compared to APOE4 carriers in early-stage dementia but not cognitively unimpaired participants.

Conclusions: The association between white matter hyperintensities and grey matter loss is more pronounced in APOE4 non-carriers than APOE4 carriers in the cognitively unimpaired and early-stage dementia stages. Furthermore, white matter hyperintensity presence results in poorer executive function in APOE4 non-carriers compared to APOE4 carriers. This finding may have significant impact on the design of clinical trials with disease modifying therapies.

Keywords: APOE4; Cognition; Cognitively normal; Dementia; Grey matter; White matter hyperintensity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Negative influence of white matter hyperintensity load on voxel-wise grey matter volume in cognitively unimpaired and early-stage dementia participants. In both cognitively unimpaired (A) and early dementia participants (B), increasing WMH load was associated with lower voxel-wise GMV across frontal, parietal, temporal, and occipital regions. Clusters showing GMV loss related to WMH are shown in red. There were no positive associations between WMH load and voxel-wise GMV. Results are shown at the uncorrected p < 0.001 height threshold with an extent threshold of 100 voxels. Results are displayed on representative sections of the MNI template brain. WMH, white matter hyperintensity; GMV, grey matter volume
Fig. 2
Fig. 2
Among cognitively unimpaired and early-stage dementia participants, APOE4 carrier status influences the effect of white matter hyperintensity load on voxel-wise grey matter volume. In both cognitively unimpaired (A) and early-stage dementia participants (B) APOE4 non-carriers, increasing WMH load was associated with widespread lower voxel-wise GMV across frontal, parietal, temporal, and occipital regions only in APOE4 non-carriers. On the other hand, in cognitively unimpaired (A) APOE4 carriers, increasing WMH load was associated with lower voxel-wise GMV only in the left middle and superior temporal pole, caudate and lingual gyrus and in early-stage dementia participants (B) only in right precentral and superior occipital gyrus. Clusters showing GMV loss related to WMH are shown in red. Results are shown at the uncorrected p < 0.001 height threshold with an extent threshold of 100 voxels. Results are displayed on representative sections of the MNI template brain. WMH, white matter hyperintensity; GMV, grey matter volume; APOE4, apolipoprotein E4
Fig. 3
Fig. 3
White matter hyperintensity load among early-stage dementia APOE4 non-carriers relates to worse cognition than APOE4 carriers. In early-stage dementia participants, there was a significant interaction effect between WMH load and APOE4 status on cognition. Increasing white matter hyperintensity load was associated with (A) lower MMSE scores and (B) poorer Color Trails 2 performance in APOE4 non-carriers compared to APOE4 carriers. The solid line refers to APOE4 non-carriers while the dashed line refers to APOE4 carriers. APOE4, apolipoprotein E4; MMSE, mini-mental state examination; WMH, white matter hyperintensity

References

    1. Tangalos EG, Petersen RC. Mild cognitive impairment in geriatrics. Clin Geriatr Med. 2018;34(4):563–589. doi: 10.1016/j.cger.2018.06.005. - DOI - PubMed
    1. Li L, Wang Y, Yan J, Chen Y, Zhou R, Yi X, et al. Clinical predictors of cognitive decline in patients with mild cognitive impairment: the Chongqing aging study. J Neurol. 2012;259(7):1303–1311. doi: 10.1007/s00415-011-6342-0. - DOI - PubMed
    1. Campbell NL, Unverzagt F, LaMantia MA, Khan BA, Boustani MA. Risk factors for the progression of mild cognitive impairment to dementia. Clin Geriatr Med. 2013;29(4):873. doi: 10.1016/j.cger.2013.07.009. - DOI - PMC - PubMed
    1. Ramirez J, McNeely AA, Berezuk C, Gao F, Black SE. Dynamic progression of white matter hyperintensities in Alzheimer’s disease and normal aging: results from the Sunnybrook dementia study. Front Aging Neurosci. 2016;8:62. doi: 10.3389/fnagi.2016.00062. - DOI - PMC - PubMed
    1. Tosto G, Zimmerman ME, Carmichael OT, Brickman AM. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities. JAMA Neurol. 2014;71(7):872–877. doi: 10.1001/jamaneurol.2014.667. - DOI - PMC - PubMed

Publication types

MeSH terms